Study results: Episealer may stop or significantly slow the process leading to OA
Study results suggest that a permanent bond may form between cartilage and the hydroxyapatite coating of Episurf’s Episealer® device, suggesting...
Feb 15, 2016,
Study results: Episealer may stop or significantly slow the process leading to OA
Strategic Orthopaedic-related 510(k)s issued in January 2016
Strategic orthopaedic-related 510(k)s issued in January 2016 include: Half Dome PLIF System (Astura Medical*), Cannulated Screw System (Epic Extremity*), Rosa Spine...
Feb 12, 2016, Julie Vetalice
Medline Expands its Foot/Ankle trauma Portfolio
Medline launched the UNITE® Foot Plating system, ARROW-LOK® Digital Fusion system and DBM putty/demineralized cancellous sponge products....
Feb 12, 2016, Julie Vetalice
Zimmer Biomet Receives FDA 510(k) Clearance for Unite3D Bridge Fixation System
Zimmer Biomet received FDA 510(k) clearance for the Unite3D™ Bridge Fixation System, 3D-printed technology designed for use in foot and ankle...
Feb 12, 2016, Julie Vetalice
RTI Surgical to License OPM’s OsteoFab 3D Printing Technology
RTI Surgical entered into an agreement with Oxford Performance Materials, gaining exclusive license for use of OsteoFab® additive manufacturing technology for...
Feb 12, 2016, Julie Vetalice
National Government Services Issues Coverage for MIS SI Joint Fusion
National Government Services issued a positive local coverage determination for MIS SI joint fusion, including SI-BONE’s iFuse procedure, effective 4/1/16....
Feb 12, 2016, Julie Vetalice
Wenzel Spine Receives FDA 510(k) Clearance for VariLift-LX
Wenzel Spine received FDA 510(k) clearance to market VariLift®-LX as a lumbar interbody fusion device for standalone use....
Feb 11, 2016, Julie Vetalice
Regentis Biomaterials Raises $15MM for U.S. Pivotal Clinical Trial
Regentis Biomaterials closed a US $15MM Series D investment round. Funds will primarily support a pivotal U.S. clinical trial of GelrinC®, a...
Feb 10, 2016, Julie Vetalice
MX Orthopedics Receives FDA Clearance for dynaMX Compression Staple
MX Orthopedics received FDA 510(k) clearance to market the dynaMX™ Compression Staple, a superelastic Nitinol-based device. ...
Feb 10, 2016, Julie Vetalice
Five-Year Results of Mobi-C Cost Utility Analysis
Studies concluded that, for patients with 2-level degenerative disc disease, cervical total disc replacement appears to be highly cost-effective vs. ACDF, and...
Feb 10, 2016, Julie Vetalice
Loading new posts...
No more posts
